Carregant...

Phenothiazines Inhibit Hepatitis C Virus Entry, Likely by Increasing the Fluidity of Cholesterol-Rich Membranes

Despite recent progress in the development of direct-acting antiviral agents against hepatitis C virus (HCV), more effective therapies are still urgently needed. We and others previously identified three phenothiazine compounds as potent HCV entry inhibitors. In this study, we show that phenothiazin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Chamoun-Emanuelli, Ana M., Pecheur, Eve-Isabelle, Simeon, Rudo L., Huang, Da, Cremer, Paul S., Chen, Zhilei
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2013
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3716126/
https://ncbi.nlm.nih.gov/pubmed/23529728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02593-12
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!